Assessment of cardiovascular risk factors in obese women with HIV

Autor: Mohammed W Ali, Ismail Ayanbisi, Simon Adamu, Fadimatu K Saad, Muhammad S Musa, Yekeen A Ayoola
Rok vydání: 2022
Předmět:
Zdroj: International Journal of STD & AIDS. 33:1206-1211
ISSN: 1758-1052
0956-4624
DOI: 10.1177/09564624221132626
Popis: Background The risk of significant weight gain/obesity associated with recently adopted antiretroviral therapy (ART) has been shown to be particularly higher among the black race, and female gender compared to their male counterparts. Herein, we evaluated and compared subclinical CVD risk between apparently healthy obese (BMI ≥30 kg/m2) and age matched normal BMI (BMI 18.5–24.9 kg/m2) women with HIV (WWH) on ART. Methods This was a hospital-based cross-sectional study of adult (≥18 years) WWH. Conventional two-dimensional echocardiography and doppler imaging parameters, lipid profile, and high sensitivity C-reactive protein (hsCRP) measures were compared between the two groups. Multivariable regression analysis was done to determine independent variables. Result A total of 60 WWH were evaluated, 30 participants in each group. The mean age of the participants and duration on ART was 36.26 ± 5.71 and 10.23 ± 5.04 (years) respectively. Measured hsCRP, total cholesterol, and low-density lipoproteins were significantly ( p = 0.002, p = 0.044, and p = 0.016 respectively) elevated in the obese group. Obese WWH had higher left atrial diameter, left atrial volume, left atrial area, aortic diameter, left ventricular mass (LVM), left ventricular mass index (LVMI), intraventricular septum in systole/diastole, left ventricular posterior wall in diastole and systole ( p < 0.001, p = 0.018, p = 0.004, p = 0.025, p < 0.001, p = 0.019/ p < 0.001, p = 0.020, and p = 0.021 respectively). On multivariable regression analysis, the measured serum biomarker hsCRP and the echocardiographic variables LVM and LVMI were independently associated ( p = 0.02, p = 0.001 and p = 0.022 respectively) with BMI. Conclusion Obese WWH had higher biomarkers of CVDs and alterations in left ventricular structure that may increase their risk for adverse cardiovascular morbidity and mortality.
Databáze: OpenAIRE